Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca abandoning anti-ovarian cancer drug, warns antidepressant not testing well
AstraZeneca abandoning anti-ovarian cancer drug, warns antidepressant not testing well
AstraZeneca abandoning anti-ovarian cancer drug, warns antidepressant not testing well
Submitted by
admin
on December 20, 2011 - 10:50am
Source:
Yahoo/AP
News Tags:
antidepressants
Targacept
ovarian cancer
AstraZeneca
TC-5214
olaparib
Headline:
AstraZeneca abandoning anti-ovarian cancer drug, warns antidepressant not testing well
Do Not Allow Advertisers to Use My Personal information
